The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services
https://www.zacks.com/stock/news/2251993/the-zacks-analyst-blog-highlights-t-mobile-us-abbott-laboratories-palo-alto-networks-enterprise-products-partners-and-the-pnc-financial-services?cid=CS-ZC-FT-press_releases-2251993
Apr 08, 2024 - T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services are part of the Zacks top Analyst Blog.
0
Top Analyst Reports for T-Mobile US, Abbott Laboratories & Palo Alto Networks
https://www.zacks.com/commentary/2251046/top-analyst-reports-for-t-mobile-us-abbott-laboratories-palo-alto-networks?cid=CS-ZC-FT-research_daily-2251046
Apr 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).
0
BIL: T-Bills Are Good, But These Funds And Asset Classes Are Better
https://seekingalpha.com/article/4682126-bil-t-bills-are-good-these-funds-and-asset-classes-are-better?source=feed_tag_etf_portfolio_strategy
Apr 04, 2024 - T-bills and BIL offer investors competitive yields with almost no risk and volatility, a solid combination. Find out my thoughts on the fund.
0
Comcast's (CMCSA) Xfinity Mobile Unveils New Value Plans
https://www.zacks.com/stock/news/2249211/comcast-s-cmcsa-xfinity-mobile-unveils-new-value-plans?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2249211
Apr 02, 2024 - Comcast's (CMCSA) Xfinity Mobile unveils new unlimited plans, offering more premium data and extra features compared with major telecom providers.
0
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
https://www.fool.com/investing/2024/03/28/bull-market-buys-3-dividend-stocks-to-own-for-the/?source=iedfolrf0000001
Mar 28, 2024 - Invest in stability, dividends, and growth with these three accomplished real estate operators.
0
Top Analyst Reports for Meta Platforms, S&P Global & AT&T
https://www.zacks.com/commentary/2246613/top-analyst-reports-for-meta-platforms-s-p-global-at-t?cid=CS-ZC-FT-research_daily-2246613
Mar 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), S&P Global Inc. (SPGI) and AT&T Inc. (T).
0
T+1 Is Wrong-Headed. Market Safety Is An Attitude, Not A Cost
https://seekingalpha.com/article/4680195-t-plus-1-is-wrong-headed-market-safety-is-an-attitude-not-a-cost?source=feed_all_articles
Mar 24, 2024 - Clearing and settlement should emphasize stability over transactions, prioritizing safety and limiting new positions for market stability.
0
A Once-in-a-Generation Investment Opportunity: 1 AI Stock to Buy Now
https://www.fool.com/investing/2024/03/24/a-once-in-a-generation-investment-opportunity-1-ai/?source=iedfolrf0000001
Mar 24, 2024 - Brookfield Infrastructure offers a unique way to invest in the data infrastructure megatrend.
0
How Big Will Starlink Become in 2024?
https://www.fool.com/investing/2024/03/24/how-big-will-starlink-become-in-2024/?source=iedfolrf0000001
Mar 24, 2024 - Starlink is getting bigger. It's also getting cheaper. For investors in a Starlink IPO, this is not necessarily a good thing.
0
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
https://www.zacks.com/stock/news/2244198/biotech-stock-roundup-gern-crnx-gain-on-updates-bmy-s-car-t-cell-therapy-news-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2244198
Mar 21, 2024 - Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.
0